Algos Preclinical Services - Latest News

Algos is an independent contract research organization specializing in preclinical in vivo pain research and program consulting. From experimental design and execution to data analysis, and from individual projects and consulting to program management, our rigorous processes and dedicated team deliver rapid and reliable results critical to drug discovery and product development. Through our commitment to customer service, we offer a flexible approach to both customized and standardized preclinical in vivo pain research that ensures our customers get the accuracy, speed, and reliability they need. Our experienced, customer-focused team of experts delivers exceptional value more cost-effectively than multi-sector preclinical CROs.
  • May 24
    Algos will be presenting and exhibiting at the World Pharma Congress, Philadelphia, PA June 7 – 9, 2011

    May 24, 2011: Algos Preclinical Services will be presenting and exhibiting at the World Pharma Congress 2011 in Philadelphia from June 7 – 9, 2011. Drop by, meet Algos team members, and hear firsthand how we can help your preclinical discovery program meet its goals. We are at Booth #25.

    1. Dr. Jim Pomonis, Algos’ Director, Scientific Affairs and Liaisons, will be presenting a talk titled “ED50s, Responder Rates and Number Needed to Treat: Can Animal Studies and Clinical Trials Speak the Same Language?” During the Drug Discovery Summit, Targeting Pain with Novel Therapeutics on Tuesday, June 7th.

    Our expertise in pain, quick turnaround and dedication to customer service provide you with the high quality definitive results you require to meet your program goals. Visit www.algosinc.com, call or email us and make us your lab down the hall.

    The Algos Team
    Phone: 651-209-0700
    Email: info@algosinc.com

  • Apr 11
    Algos is Expanding and Hires Cara Wykowski in Business Development

    April 11, 2011: Algos Preclinical Services, Inc. (Algos) is pleased to announce that Cara Wykowski has joined as Director, Business Development. Cara was formerly with The Jackson Laboratory specializing in complete colony management and preclinical efficacy studies in the areas of metabolics, oncology and autoimmune diseases. Cara has over 18 years of sales and business development experience in the life sciences industry. “We are excited that Cara has joined us and it has allowed us to double our business development efforts and increase our focus on proactive customer service”, said Ganesh Iyer, President and CEO of Algos.

    Based in the San Francisco Bay area, Cara started with Algos last month and will be responsible for developing and expanding business in the Western US/ Canada, South America, Asia and Australia. Mr. Frank Eichmann will continue to be responsible for business development and growth in the Eastern US/Canada, Europe, Middle-East and Africa.

    Algos is a premier contract research organization focusing on preclinical pain in vivo services and providing critical support to its clients in the pharma/biotech and medical device industries. Algos delivers the timely and definitive results that its clients count on to maintain their first to market advantage. This has allowed Algos to help its clients to make uninterrupted progress on their development candidates, despite the tumultuous times in the pharma/biotech sector in general in recent years. Algos is experiencing an increase in demand for its services and is poised for continued growth.

    • « 2009       Newer Entries »

Algos: The premier CRO in pain preclinical drug development

Algos Preclinical Services, a Contract Research Organization (CRO), specializes in preclinical in vivo pain research and program consulting. We deliver unparalleled customer service through a flexible approach to both customized and standardized pain research that allows us to provide our customers with the accurate, reliable results they depend on. Our team of experts is the premier intellectual resource for planning, executing, and managing in vivo pharmacology research in neuroscience and pain. In-house pain research expertise, outstanding customer service, and rapid, reliable results combine to create exceptional value for our clients.


Contact Algos Preclinical Services, a cost-effective extension of your in-house research department for preclinical in vivo pain research.